Balzide 750mg Capsules
Out of date information, search anotherBALZIDE 750 mg CAPSULES BALSALAZIDE DISODIUM 750 mg CAPSULES (balsalazide disodium)
Patient Information Leaflet
This product is known by the above names but will usually be referred to as Balzide throughout this leaflet.
Read all of this leaflet carefully before you start taking this medicinal product because it contains important information for you.
• Keep this leaflet as you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
What is in this leaflet:
1. What Balzide is and what it is used for
2. What you need to know before you take Balzide
3. How to take Balzide
4. Possible side effects
5. How to store Balzide
6. Contents of the pack and other information
1. What Balzide is and what it is used for
Balzide is a medicine with the property to release a substance called mesalazine, which acts as an intestinal anti-inflammatory drug, with a localised action on the inner lining (mucosa) of the large bowel (colon). Ulcerative colitis is a disease characterised by inflammation of the inner layer (mucosa) of the large bowel (colon) and rectum. Balzide acts locally, reducing the inflammation (treatment of the active phase). Balzide can be used to prevent further aggravation of the symptoms, after their onset (maintenance phase treatment).
Balzide 750-mg capsules are used to treat slight to moderate ulcerative colitis either in the active phase or as maintenance therapy.
Balzide is indicated in adults.
2. What you need to know before you take Balzide
Do not take Balzide:
• if you are allergic (hypersensitive) to balsalazide or mesalazine, or any of the other ingredients of Balzide (listed in section 6).
• if you are allergic (hypersensitive) to acetylsalicylic acid and its derivatives.
• if you are pregnant or breast-feeding.
• if you suffer from moderate to severe kidney disorders.
• if you suffer from severe liver disorders.
Warnings and precautions
Talk to your doctor or pharmacist before taking Balzide if you:
• have liver disease or mild kidney problems
• suffer from asthma
• have a bleeding disorder
• have an active peptic ulcer
Please inform your doctor before taking Balzide if you suffer from any of these conditions.
Tests on your liver, kidney and blood
Before you start treatment with Balzide you will have a blood and urine test to check how well your kidneys are working and what your blood is doing. During treatment your doctor will check how well your liver, kidney and blood is working by taking blood and urine samples periodically during your treatment.
Stop treatment immediately if you suspect a blood complication either on the basis of the results from blood tests or from symptoms which may include, for example, one or more of the following; unexplained bleeding, bruising, sore throat, fever, malaise or purple spots/blotches on the skin (purpura).
Children and adolescents (under the age of 18)
Children should not use Balzide.
Other medicines and Balzide
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
The effect of the treatment could be influenced by other medicinal products, if taken together with Balzide. It may be necessary to reduce the dose, or to take other precautions, or in some cases to stop taking one of the medicines. This applies to any medicines, even those not requiring a medical prescription, especially:
• digitalis (digoxin), a medicine for the heart, whose blood levels may be reduced in patients that are also taking Balzide
• methotrexate, a medicine used to treat some forms of arthritis, tumours and psoriasis, as its clearance by the kidneys may be reduced in patients that are also taking Balzide.
Balzide with food and drink
Balzide must be taken on a full stomach.
Pregnancy and breast-feeding
Do not take Balzide during pregnancy or breast-feeding.
Driving and using machinery
No relevant effects of Balzide are known.
3. How to take Balzide
Always follow the doctor's instructions carefully while using Balzide, in order to obtain the best results and reduce the risk of any side effects. If you have any doubts, contact your doctor or pharmacist.
Ulcerative colitis - treatment of the active phase: the dose is 3 capsules of Balzide (2.25 grams) 3 times a day (6.75 grams/day) until the symptoms wear off, or up to a maximum of 12 weeks. If necessary, steroids may be given in addition.
Ulcerative colitis - maintenance phase treatment: the initial dose recommended is 2 capsules of Balzide (1.5 grams) twice a day (3 grams/day). Further benefit may be obtained by taking a dose of up to 8 capsules a day (6 grams).
Elderly patients (65 years and over)
Balzide can also be used in patients 65 or older without any dose adjustment.
Your doctor may prescribe doses for you that are different from those indicated in this information leaflet. If this happens, ask your doctor for further information.
Whilst taking this medicine ensure you drink adequate fluids to remain well hydrated, especially after severe or prolonged episodes of vomiting and/or diarrhoea, high fever or heavy sweating. This is to avoid problems with your kidneys.
Balzide capsules must be swallowed whole on a full stomach.
If you take more Balzide than you should
If you have taken too many capsules, contact your doctor, pharmacist, ora hospital immediately.
If you forget to take Balzide
Do not take a double dose to make up for a forgotten dose.
If you stop taking Balzide
Stopping treatment with Balzide could cause your disease to get worse. Do not stop taking the medicine
unless advised to do so by your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, Balzide can cause side effects, although not everybody gets them.
Stop taking the medicine and tell your doctor immediately if you:
• have allergic reactions, such as reddening of the skin (rash), breathing disorders (bronchospasm), allergic pneumonia (symptoms include breathing difficulty, wheezing, and dry coughs, accompanied by chills, sweating and aching)
• suffer from any blood disorders with symptoms such as unexplained bleeding, bruising, purple spots/blotches on the skin (purpura), sore throat, fever, malaise or have blood test changes that indicate blood disorders (decreased white blood cells, red blood cells, and platelets)
• have skin signs, such as reddening of the face with skin peeling, pain and reddening of the inside of the mouth (a syndrome similar to lupus erythematosus)
The most common adverse side effects are:
• headache
• gastrointestinal disorders (stomach-ache, diarrhoea, nausea and vomiting)
Very rarely the following have been reported:
• Gallstones
• Worsening of the colitis symptoms (e.g. drastic change in stool frequency, watery diarrhoea that may contain blood, mucus, and/or pus)
• Inflammation of the kidneys (nephritis), with fever, increased passing water, cloudy or bloody urine, abdominal pain and fatigue as possible symptoms
• Inflammation of the pancreas (acute pancreatitis), with nausea, vomiting, fever, sweating, yellowing of the skin as possible symptoms
• Inflammation of the liver (hepatitis), with tiredness, fever, loss of appetite, feeling sick or vomiting, muscle aches and joint pain, yellowish eyes and skin as possible symptoms
• Inflammation of the heart (myocarditis and pericarditis), with chest pain, heart palpitations, fatigue, shortness of breath as possible symptoms
• Joint pain
• Muscular pain
• Disorders of the peripheral nerves (neuropathies), with e.g. a tingling or burning sensation, or pain and numbness
• Hair loss.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Balzide
• Do not use after the expiry date printed on the carton or container label.
• Balzide 750 mg Capsules/Balsalazide disodium 750 mg Capsules should be stored in the original container.
• KEEP ALL MEDICINES OUT OF THE SIGHT AND REACH OF CHILDREN.
• If your doctor tells you to stop taking the capsules, please take them back to the pharmacist for safe disposal. Only keep the capsules if your doctor tells you to.
• If the capsules become discoloured or show any other signs of deterioration, you should seek the advice of your pharmacist.
6. Contents of the pack and other information
Your medicine is called Balzide 750 mg Capsules/Balsalazide disodium 750 mg Capsules. It contains 750 mg of the active ingredient balsalazide disodium in a gelatin capsule with a white body marked with a ‘M' and an unmarked, blue coloured cap.
Balzide 750 mg Capsules/Balsalazide disodium 750 mg Capsules also contain the following:
Magnesium stearate, gelatin, colloidal anhydrous silica, shellac, titanium dioxide (E171), black iron oxide (E172)and indigotine (E132).
Balzide 750 mg Capsules/Balsalazide disodium 750 mg Capsules are available as packs of 112 capsules.
POM PL No: 6464/2204
This product is manufactured A. Menarini Sud S.r.l., Via Campo di Pile, 67100, L'Aquila, Italy and is procured from within the EU and repackaged by the Product Licence holder:
Waymade Plc, Miles Gray Road, Basildon, Essex. SS14 3FR
Leaflet revision and issue date (Ref.) 1.4.2014
BALZIDE is a registered trademark of MENARINI INTERNATIONAL
000-0000D
V